Follow the latest news and projects about COVID-19 and the European Commission's coronavirus response.

Skip to main content
EnglishEN

Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy

Project description

DEENESFRITPL

Recreating a patient's tumour ecoystem with 3D printing will foster precision treatment

Field of science

  • /social sciences/economics and business
  • /natural sciences/biological sciences/biophysics
  • /medical and health sciences/clinical medicine/oncology/cancer

Programme(s)

Topic(s)

Call for proposal

ERC-2019-PoC
See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

TEL AVIV UNIVERSITY
Address
Ramat Aviv
69978 Tel Aviv
Israel
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 150 000
Website Opens in new window
Contact the organisation Opens in new window

Beneficiaries (1)

TEL AVIV UNIVERSITY
Israel
EU contribution
€ 150 000
Address
Ramat Aviv
69978 Tel Aviv
Activity type
Higher or Secondary Education Establishments
Website Opens in new window
Contact the organisation Opens in new window

share_this_page

download

last_update: 28 months.month_08 2019
rcn: 224839

Permalink: https://cordis.europa.eu/project/id/862580/

© European Union, 2020